IQVIA & NVIDIA Partner to Advance AI in Healthcare & Life Sciences

The collaboration includes access to NVIDIA’s NIM microservices, NeMo, DGX Cloud platform, and AI Blueprint for multi-modal data extraction.

IQVIA, a global leader in clinical research and healthcare intelligence, has announced a strategic partnership with NVIDIA to harness the potential of artificial intelligence (AI) in healthcare and life sciences.

The collaboration aims to accelerate the development and deployment of AI-powered solutions to streamline workflows across the therapeutic lifecycle and improve patient outcomes.

The healthcare and life sciences industries generate vast amounts of data, offering significant opportunities for AI to transform processes.

IQVIA plans to drive innovation by leveraging its Connected Intelligence platform, which integrates information assets, analytics, and domain expertise, with NVIDIA’s cutting-edge AI Foundry service.

Enhancing Healthcare-grade AI Solutions

This partnership will enable IQVIA to enhance its Healthcare-grade AI capabilities with the precision, scalability, and trust required by its clients.

Bhavik Patel, President of Commercial Solutions at IQVIA, said, “This represents a significant leap forward in how we apply AI to healthcare and life sciences. Combining IQVIA’s decade-long expertise in AI with NVIDIA’s advanced technologies will help accelerate innovation and bring treatments to market faster.”

Kimberly Powell, Vice President of Healthcare at NVIDIA, emphasized the transformative potential of the collaboration.

“By integrating NVIDIA’s AI Foundry platform, IQVIA can develop custom, domain-specific models and agents for complex workflows, enabling researchers, doctors, and patients to unlock productivity and expand access to care globally,” she said.

Expanding AI Applications in Life Sciences

The collaboration includes access to NVIDIA’s NIM microservices, NeMo, DGX Cloud platform, and AI Blueprint for multi-modal data extraction.

These tools will help create custom AI agents designed to streamline processes in drug development, clinical trials, and commercialization.

The AI agents are expected to act as digital companions, improving efficiency and precision in research and patient care.

IQVIA and NVIDIA aim to launch their initial AI solutions within the current calendar year.

By combining IQVIA’s robust data assets and industry expertise with NVIDIA’s AI innovations, the partnership seeks to introduce new efficiencies, enable innovative operating models, and deliver enhanced patient outcomes.

This collaboration underscores the growing role of AI in healthcare and life sciences, addressing the need for advanced solutions to manage complex workflows and unlock the potential of vast data resources.

Stay tuned for more such updates on Digital Health News.